Fiscal Year End Company Status Exempt Flag February 29 Trading N Board of Directors Name Position Henri Harland  Director of the Board   Corporate Secretary Marc Lebel  Director of the Board Martin Godbout  Director of the Board Michel Chartrand  Director of the Board Ronald Denis  Chairperson of the Board Tina Sampalis  President Incorporation Locations Inc. Date Expiry Date Country Region Description 1/Feb/2002    Canada  Quebec    Exchange Filing Office Location Montreal Regional Service Office		Business Type(s) Primary/Secondary Business Type Details Primary  Research and Development in the Physical, Engineering and Life Sciences  (not available)  Securities Symbol Security Name Market Status APO Acasti Pharma Inc. TSX Venture TRADING Name History From To Acasti Pharma Inc. 8/Nov/2010 Present Company Facts Reconciliation Subject Date Returned Spring 2012 CFR 9/May/2012 Associations Auditing Firm:  KPMG LLP Transfer Agent:  Computershare Investor Services Inc.
Latest Information Type Date Title News Releases  4/Dec/2012  NEWS RELEASE - IIROC TRADING RESUMPTION ACASTI PHARMA INC.[MARKET NEWS]     NEWS RELEASE - IIROC TRADING HALT RE ACASTI PHARMA INC PENDING[MARKET NEWS]     NEWS RELEASE - ACASTI PHARMA BECOMES ROYALTY FREE[MARKET NEWS] Bulletins  4/Dec/2012  Halt Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations (not available)

* Historical Data